132748-10-8

Basic information

• Product Name: 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-b,d,8-trihydroxy-2,6-dimethyl-, (bR,dR,1S,2S,6R,8S,8aR)-
• CAS NO: 132748-10-8
• Molecular Formula: C19H30O5
• Molecular Weight: 338.444
• Mol File: 132748-10-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-b,d,8-trihydroxy-2,6-dimethyl-, (bR,dR,1S,2S,6R,8S,8aR)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-b,d,8-trihydroxy-2,6-dimethyl-, (bR,dR,1S,2S,6R,8S,8aR)-(132748-10-8)
• EPA Substance Registry System: 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-b,d,8-trihydroxy-2,6-dimethyl-, (bR,dR,1S,2S,6R,8S,8aR)-(132748-10-8)

Safety Data

• Hazardous Substances Data: 132748-10-8(Hazardous Substances Data)

Usage

Molecular family

Tocopherols
A family of compounds that include various forms of vitamin E.

Molecular structure

Complex organic compound
The intricate arrangement of atoms and bonds in the molecule.

Solubility

Fat-soluble
Capable of dissolving in fats and lipids, which allows it to be absorbed and utilized by the body.

Antioxidant properties

Potent

Essential for human health

Proper functioning

Natural sources

Plant-based oils
Commonly found in various plant-based oils, such as sunflower, olive, and soybean oil.

Dietary supplement

Prevents or treats deficiency
Used as a supplement to ensure adequate intake of vitamin E and prevent or treat deficiencies.

Skincare and cosmetic applications

Important component
Due to its antioxidant properties, it is a key ingredient in many skincare and cosmetic products to protect and nourish the skin.

Upstream product

• 75225-51-3 lovastatin acid 
• 851402-85-2 bis-simvastatin 
• 75330-75-5 lovastatin 

Downstream Products

• 121009-77-6 simvastatin acid 
• 139893-43-9 simvastatin ammonium salt 
• 1002347-71-8 C₂₅H₃₂⁽²⁾H₆O₅ 
• 1335460-29-1 C₃₁H₄₆⁽²⁾H₆O₅Si 
• 75225-51-3 lovastatin acid 
• 151006-15-4 (4R,6R)-4-hydroxy-6-(2-((1S,2S,6R,8S,8aR)-8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl)tetrahydro-2H-pyran-2-one 
• 145576-24-5 C₂₁H₃₀O₅ 
• 850920-00-2 C₂₃H₃₂O₆ 
• 81189-92-6 (S)-2-methyl-butyric acid (3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-acetoxy-6-oxo-tetrahydro-pyran-2yl]-ethyl}-3,7-dimetyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester 
• 79902-31-1 (4R,6R)-6-[2-((1S,2S,6R,8S,8aR)-8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthyl)ethyl]-4-[(tert-butyldimethylsilyl)oxy]-3,4,5,6-tetrahydro-2H-pyran-2-one 
• 101314-97-0 simvastatin sodium salt 
• 76343-78-7 6 (R)-[2-[8'(S)-hydroxy-2'(S),6'(R)-dimethyl-1',2',6',7',8',8a'(R)-hexahydronaphthyl-1'(S)] ethyl]-4 (R)-hydroxy-3, 4, 5, 6-tetrahydro-2H-pyran-2-on 

Relevant articles and documents

HYPOCHOLESTEROLEMIC, ANTI-INFLAMMATORY AND ANTIEPILEPTIC NEUROPROTECTIVE COMPOUND

The present invention describes a compound of formula (I) its hydroxy acid form, the pharmaceutically acceptable salts of said hydroxy acid and pharmaceutically acceptable prodrugs and solvates of the compound and of its hydroxy acid form and, in particular, said compound, its hydroxy acid form, salts, etc. for use in the prevention of: neurodegenerative diseases, cognitive impairment, diseases associated with undesired oxidation, age-associated pathological processes and progeria, cardiovascular diseases such as atherosclerosis, atrial fibrillation, dyslipidemia, hypercholesterolemia, hyperlipidemia, and hypertriglyceridemia, inflammation or inflammatory processes, or epilepsy, epileptic seizures and convulsions.